G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 120 filers reported holding G1 THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 58.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $69 | -21.6% | 25,820 | +58.5% | 0.01% | -33.3% |
| Q4 2022 | $88 | -100.0% | 16,291 | +9.3% | 0.01% | -50.0% |
| Q3 2022 | $186,000 | +1.1% | 14,901 | -38.4% | 0.02% | -18.2% |
| Q1 2022 | $184,000 | -23.3% | 24,187 | +81.6% | 0.02% | -43.6% |
| Q4 2020 | $240,000 | +3.4% | 13,319 | -33.7% | 0.04% | +5.4% |
| Q3 2020 | $232,000 | +5.9% | 20,085 | +122.9% | 0.04% | +12.1% |
| Q2 2020 | $219,000 | -2.2% | 9,010 | -33.2% | 0.03% | -10.8% |
| Q1 2019 | $224,000 | -18.2% | 13,488 | +157.9% | 0.04% | -2.6% |
| Q3 2018 | $274,000 | – | 5,230 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 98,482 | $1,631,000 | 0.60% |
| Opus Point Partners Management, LLC | 20,844 | $346,000 | 0.47% |
| HHLR ADVISORS, LTD. | 949,431 | $15,761,000 | 0.44% |
| Rhenman & Partners Asset Management AB | 212,169 | $3,522,000 | 0.41% |
| Virtus ETF Advisers LLC | 8,654 | $144,000 | 0.31% |
| BB BIOTECH AG | 671,925 | $11,154,000 | 0.28% |
| RA Capital Management | 363,051 | $6,027,000 | 0.26% |
| BDO Wealth Advisors, LLC | 35,234 | $585,000 | 0.17% |
| Birchview Capital, LP | 15,000 | $249,000 | 0.16% |
| SECOR Capital Advisors, LP | 37,205 | $618,000 | 0.13% |